Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3048% below fair value
$145.34+0.05 (+0.03%)
Close on Nov 17, 2026Market cap $10.08BP/E 23.7Yield –
Insulet net income
Net income is the profit left for shareholders after every expense, interest and tax.
Insulet's net income for the twelve months ending Sep 30, 2026 was $428.80M, up 74.2% year over year. For fiscal 2025 it was $247.10M, down 40.9% from the year before. The highest annual figure on record is $418.30M in fiscal 2024.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $247.10M | -40.9% |
| FY2024 | Dec 31, 2024 | $418.30M | +102.8% |
| FY2023 | Dec 31, 2023 | $206.30M | +4384.8% |
| FY2022 | Dec 31, 2022 | $4.60M | -72.6% |
| FY2021 | Dec 31, 2021 | $16.80M | +147.1% |
| FY2020 | Dec 31, 2020 | $6.80M | -41.4% |
| FY2019 | Dec 31, 2019 | $11.60M | +251.5% |
| FY2018 | Dec 31, 2018 | $3.30M | – |
| FY2017 | Dec 31, 2017 | -$26.80M | – |
| FY2016 | Dec 31, 2016 | -$28.88M | – |
| FY2015 | Dec 31, 2015 | -$73.52M | – |
| FY2014 | Dec 31, 2014 | -$51.50M | – |
| FY2013 | Dec 31, 2013 | -$44.97M | – |
| FY2012 | Dec 31, 2012 | -$51.87M | – |
| FY2011 | Dec 31, 2011 | -$45.83M | – |
| FY2010 | Dec 31, 2010 | -$61.16M | – |
| FY2009 | Dec 31, 2009 | -$72.34M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $141.10M | +61.1% |
| Q2 FY2026 | Jun 30, 2026 | $95.00M | +322.2% |
| Q1 FY2026 | Mar 31, 2026 | $91.10M | +157.3% |
| Q4 FY2025 | Dec 31, 2025 | $101.60M | +0.9% |
| Q3 FY2025 | Sep 30, 2025 | $87.60M | +13.0% |
| Q2 FY2025 | Jun 30, 2025 | $22.50M | -88.1% |
| Q1 FY2025 | Mar 31, 2025 | $35.40M | -31.3% |
| Q4 FY2024 | Dec 31, 2024 | $100.70M | -2.5% |
| Q3 FY2024 | Sep 30, 2024 | $77.50M | +49.3% |
| Q2 FY2024 | Jun 30, 2024 | $188.60M | +590.8% |
| Q1 FY2024 | Mar 31, 2024 | $51.50M | +116.4% |
| Q4 FY2023 | Dec 31, 2023 | $103.30M | +507.6% |
| Q3 FY2023 | Sep 30, 2023 | $51.90M | – |
| Q2 FY2023 | Jun 30, 2023 | $27.30M | – |
| Q1 FY2023 | Mar 31, 2023 | $23.80M | -14.4% |
| Q4 FY2022 | Dec 31, 2022 | $17.00M | -41.8% |
| Q3 FY2022 | Sep 30, 2022 | -$5.20M | -141.3% |
| Q2 FY2022 | Jun 30, 2022 | -$35.00M | – |
| Q1 FY2022 | Mar 31, 2022 | $27.80M | – |
| Q4 FY2021 | Dec 31, 2021 | $29.20M | – |
| Q3 FY2021 | Sep 30, 2021 | $12.60M | +8.6% |
| Q2 FY2021 | Jun 30, 2021 | -$25.00M | -273.6% |
| Q1 FY2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | -$17.10M | -442.0% |
| Q3 FY2020 | Sep 30, 2020 | $11.60M | +1350.0% |
| Q2 FY2020 | Jun 30, 2020 | $14.40M | +928.6% |
| Q1 FY2020 | Mar 31, 2020 | -$2.10M | -147.7% |
| Q4 FY2019 | Dec 31, 2019 | $5.00M | -49.5% |
| Q3 FY2019 | Sep 30, 2019 | $800.00K | -52.9% |
| Q2 FY2019 | Jun 30, 2019 | $1.40M | – |
| Q1 FY2019 | Mar 31, 2019 | $4.40M | – |
| Q4 FY2018 | Dec 31, 2018 | $9.90M | – |
| Q3 FY2018 | Sep 30, 2018 | $1.70M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.70M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.60M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.86M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.23M | – |
| Q2 FY2017 | Jun 30, 2017 | -$7.77M | – |
| Q1 FY2017 | Mar 31, 2017 | -$9.98M | – |
| Q4 FY2016 | Dec 31, 2016 | -$9.12M | – |
See a number that looks wrong?